Medtronic (NYSE:MDT) today announced CE mark approval and the first commercial European implants for its OmniaSecure system.
Irish medtech giant Medtronic has secured another US approval for its OmniaSecure defibrillation lead, expanding its use to placement in the left bundle branch (LBB) area of the heart. Medtronic first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results